Iceland· IS-EU/1/23/1722/002
Akeega
A niraparib and abiraterone product containing abirateronum inn acetat,niraparibum inn tósýlat mónóhýdrat, registered in Iceland by Janssen-Cilag International NV*. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Niraparib and abiraterone is registered in 11 of 19 countries.
Countries holding a registration under ATC L01XK52 (niraparib and abiraterone), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Niraparib and abiraterone · ATC L01XK52
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Abirateronum INN acetat,Niraparibum INN tósýlat mónóhýdrat
- Manufacturer
- Janssen-Cilag International NV*
- Country
- Iceland (IS)
- ATC code
- L01XK52
- ATC class
- Niraparib and abiraterone
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Niraparib and abiraterone in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAKEEGAJanssen Biotech, Inc.
- SwitzerlandAkeega
- CzechiaAKEEGAJanssen-Cilag International N.V., Beerse
- SpainAKEEGA 100 MG/500 MG COMPRIMIDOS RECUBIERTOS CON PELICULAJanssen-Cilag International N.V
- FinlandAkeegaJanssen-Cilag International NV
- SwedenAkeega 100 mg/500 mg Filmdragerad tablettJanssen-Cilag International NV
- CanadaAKEEGAJANSSEN INC
- United KingdomAkeega 100mg/500mg tabletsJanssen-Cilag Ltd
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Akeega
- Norway · Akeega
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5dc1e0f-8be4-4133-bdad-6c94c236b3ee GET /v1/drugs/e5dc1e0f-8be4-4133-bdad-6c94c236b3ee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "L01XK52",
"marketed": true,
"strength": "100 mg/500 mg",
"ma_number": "EU/1/23/1722/002",
"substance": "Abirateronum INN acetat,Niraparibum INN tósýlat mónóhýdrat",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í krabbameinslækningum og þvagfæraskurðlækningum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "45035"
}See everything about niraparib and abiraterone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.